<DOC>
	<DOC>NCT00758667</DOC>
	<brief_summary>The purpose of this study is to make available an agent,Mesna, which can assist the surgeon during the procedure of capsulectomy.</brief_summary>
	<brief_title>Chemically Assisted Capsulectomy-A New Clinical Approach</brief_title>
	<detailed_description>Mesna is a FDA approved drug for the treatment of respiratory diseases and is used a protective agent against drugs in oncology patients. It has also been used in Gynecologic surgery and ENT. Mesna is a drug that breaks down adhesions between tissue layers.</detailed_description>
	<mesh_term>Contracture</mesh_term>
	<mesh_term>Implant Capsular Contracture</mesh_term>
	<mesh_term>Mesna</mesh_term>
	<criteria>All females undergoing capsulectomy All pregnant women and nursing mothers will be exclued</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>capsular contracture</keyword>
	<keyword>capsulectomy</keyword>
	<keyword>mesna</keyword>
	<keyword>Capsular contracture after breast implant placement</keyword>
</DOC>